Peptides & Peptide Synthesis Products

Boc-Asn-OH

Boc-Asn-OH

$4.00
$4.00
Boc-Asn-OH, Catalog No: 48016
N2-[(tert-Butoxy)carbonyl]-L-asparagine , CAS: 7536-55-2, MW: 232.23, Formula: C9H16N2O5
Catalog No: 48016
N2-[(tert-Butoxy)carbonyl]-L-asparagine
, CAS: 7536-55-2, MW: 232.23, Formula: C9H16N2O5
Description

Details

N2-[(tert-Butoxy)carbonyl]-L-asparagine
Additional Information

Additional Information

Catalog Number 48016
CAS 7536-55-2
M.W. 232.23
Formula C9H16N2O5
IUPAC Name (2S)-4-amino-2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-oxobutanoic acid
Synonym N2-[(tert-Butoxy)carbonyl]-L-asparagine
Also Known As
  • (2S)-4-amino-2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-oxobutanoic acid
  • (2S)-4-amino-2-(tert-butoxycarbonylamino)-4-oxo-butanoic acid
  • (2S)-4-amino-2-[(tert-butoxy-oxomethyl)amino]-4-oxobutanoic acid
  • (2S)-4-amino-2-(tert-butoxycarbonylamino)-4-keto-butyric acid
  • (2S)-4-amino-2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-oxo-butanoic acid
  • 7536-55-2
  • N2-((tert-Butoxy)carbonyl)-L-asparagine
  • 15381_FLUKA
  • Boc-Asn-OH
  • Boc-L-asparagine
  • Nalpha-(tert-Butoxycarbonyl)-L-asparagine
  • L-Asparagine, N2-((1,1-dimethylethoxy)carbonyl)-
  • EINECS 231-405-2
  • Boc-Asn
  • C01410
  • N-alpha-Boc-L-asparagine
  • NSC 154980
  • N2-((1,1-Dimethylethoxy)carbonyl)-L-asparagine
  • ST5307208
InChIKey FYYSQDHBALBGHX-YFKPBYRVSA-N
InChI InChI=1S/C9H16N2O5/c1-9(2,3)16-8(15)11-5(7(13)14)4-6(10)12/h5H,4H2,1-3H3,(H2,10,12)(H,11,15)(H,13,14)/t5-/m0/s1
SMILES CC(C)(C)OC(=O)N[C@@H](CC(=O)N)C(=O)O
Cited Uses

Details

1. Giubellino A et al, "Selectivity and Mechanism of Action of a Growth Factor Receptor-Bound Protein 2 Src Homology 2 Domain Binding Antagonist", Journal of medicinal chemistry, 51(23) pp.7459-7468 (2008 Dec 11).
2. Choi WJ et al, "Application of Azide-Alkyne Cycloaddition Click Chemistry for the Synthesis of Grb2 SH2 Domain-Binding Macrocycles", Bioorganic & medicinal chemistry letters, 16(20) pp.5265-5269 (2006 Oct 15).
3. Abiko T et al, "Syntheses of two deacetyl-thymosin ?1 analogues and their effects on low E-rosette-forming lymphocytes of uraemic patients", Mediators of Inflammation, 5(4) pp.295-298 (1996 Sep).
4. Izdebski J et al, "Synthesis and biological evaluation of superactive agonists of growth hormone-releasing hormone.", Proceedings of the National Academy of Sciences of the United States of America, 92(11) pp.4872-4876 (1995 May 23).
5. Li CH et al, "Gonadotropin-releasing peptide from human follicular fluid: isolation, characterization, and chemical synthesis.", Proceedings of the National Academy of Sciences of the United States of America, 84(4) pp.959-962 (1987 Feb).
6. Toida I et al, "Lack of tuberculin activity of synthetic peptides.", Infection and Immunity, 50(3) pp.614-619 (1985 Dec).
7. Yamashiro D et al, "Synthesis and biological activity of human inhibin-like peptide-(1-31).", Proceedings of the National Academy of Sciences of the United States of America, 81(17) pp.5399-5402 (1984 Sep).
8. Andreu D et al, "Solid-phase synthesis of cecropin A and related peptides.", Proceedings of the National Academy of Sciences of the United States of America, 80(21) pp.6475-6479 (1983 Nov).
9. Li CH et al, "Total synthesis of insulin-like growth factor I (somatomedin C).", Proceedings of the National Academy of Sciences of the United States of America, 80(8) pp.2216-2220 (1983 Apr).
Reviews
cr